A reformulated ‘less painful’ version of Humira will be listed on the PBS from April 1, along with four adalimumab biosimilars accepted into the Australian subsidy scheme. AbbVie’s revised version of its best-selling anti-TNF drug has been available for some years in overseas markets and is documented as causing less pain and discomfort on injection ...
Less painful Humira injections and four biosimilars listed on PBS
By Julie Lambert
31 Mar 2021